Virtual screening and molecular mechanism of novel anti-benign prostatic hyperplasia peptides from Syngnathus schlegeli
Abstract
Benign prostatic hyperplasia (BPH) is a common degenerative urinary system among old men. The marine pipefish (Syngnathus schlegeli) exhibited potential reproductive health benefits. However, its mechanisms and active components in alleviating BPH remain unclear. The S. schlegeli extract (SN, 200 mg/kg) prepared by enzymatic hydrolysis and ultrafiltration significantly reduced the prostate tissue weight 25 % approximately (p < 0.01) in a testosterone propionate (TP) induced BPH rat. Pathological analysis revealed a significant reduction in epithelial cell thickness and collagen fiber area (p < 0.001) and regulated serum dihydrotestosterone, prostate-specific antigen, 5α-reductase, pro-inflammatory factors, and oxidative stress markers. The transcriptomics, targeted-metabolomics, quantitative real-time polymerase chain reaction analysis (qRT-PCR), and western blotting (WB) assay revealed that SN alleviates BPH by binding to extracellular matrix receptor and inhibiting PI3K-Akt and NF-κB pathways. A peptide library constructed based on nano-LC-MS/MS identified 9209 peptides, and combined with network pharmacology and molecular docking, three highly active peptides (DGFR, LMDK, and KPF) were selected, and confirmed to inhibit the proliferation of TP-induced RWPE-1 cells with IC50 lower than RGD (Arg-Gly-Asp). Quantum chemical analyses indicated that the short peptide structures of N-terminal branched-chain, hydrophobic and polar amino acids contribute to anti-BPH activity.…
Read the paper
Related studies
- Induced osteoblast differentiation by amide derivatives of stilbene: The possible osteogenic agents
- On model selections for repeated measurement data in clinical studies
- Regulation of GLUT transporters by flavonoids in androgen-sensitive and -insensitive prostate cancer cells
- Region-specific microRNA signatures in the human epididymis
- Synthesis, biological evaluation and molecular docking of 4-Amino-2H-benzo[h]chromen-2-one (ABO) analogs containing the piperazine moiety
- In Vitro characterization of the endocrine disrupting effects of per- and poly-fluoroalkyl substances (PFASs) on the human androgen receptor
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.